HARMONY BIOSCIENCES HOLDINGS, INC. Accumulated Other Comprehensive Income
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) had Accumulated Other Comprehensive Income of -$727.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$727.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$413.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $346.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $357.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$727.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | -$413.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $346.00K 10-Q · filed 2026-08-04 |
| 2025-09-30 | $357.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $239.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $245.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $66.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $499.00K 10-Q · filed 2024-10-29 |
| 2024-06-30 | -$234.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$171.00K 10-Q · filed 2024-04-30 |
| 2023-12-31 | $2.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | -$516.00K 10-Q · filed 2023-10-31 |
| 2023-06-30 | -$522.00K 10-Q · filed 2023-08-01 |
| 2023-03-31 | -$31.00K 10-Q · filed 2023-05-02 |
| 2022-12-31 | -$151.00K 10-K · filed 2024-02-22 |
| 2022-09-30 | -$178.00K 10-Q · filed 2022-11-01 |
| 2022-06-30 | -$29.00K 10-Q · filed 2022-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |